Search

A study conducted in Alberta, Canada, has found that there are significant disparities in cancer diagnosis and survival rates based on neighborhood-level income. This is also seen in the United States, where low socioeconomic status is correlated with advanced stage diagnosis. In Italy, a national screening program has helped reduce disparities, but barriers to access still exist. The report by Antonio V. Sterpetti, Raimondo Gabriele, Immacolata Iannone, Luca Dimarzo, and Valeria Borrelli provides an objective analysis of this topic. [Extracted from the article]

The article discusses the impact of education and expenditure on cancer screening adherence rates in Europe and the United States. Factors such as community awareness and access to care play a crucial role in improving screening rates. In Europe, lower adherence rates are associated with educational level, household income, and access to care. The study emphasizes the importance of appropriate spending on education and information to reduce barriers to screening, especially for individuals with lower socioeducational levels. [Extracted from the article]

The article discusses a study on colorectal cancer survival rates in seven European countries, highlighting differences in 5-year survival rates by stage. Countries with screening programs showed decreased incidence and mortality rates, emphasizing the importance of early detection. The study underscores the correlation between national expenditure on preventive care and screening program implementation with mortality rates. Overall, the research supports the benefits of prevention and early diagnosis in improving outcomes and reducing costs related to colorectal cancer. [Extracted from the article]

A study published in the International Journal of Cancer analyzed the impact of the COVID-19 pandemic on cancer diagnosis and treatment. The study found that there was a significant decrease in the number of new cancer diagnoses in the United States during the first year of the pandemic, with diagnoses often being made at more advanced stages. This decrease was particularly pronounced in historically marginalized populations. Fear of contamination and limited access to healthcare services were identified as factors contributing to the underdiagnosis of cancer. However, the study also found that medical and surgical activity began to return to pre-pandemic levels in 2021 and 2022, with screening for breast, prostate, and cervical cancer returning to normal. The authors concluded that the medical system has been able to mitigate the negative effects of the pandemic, and they expect a similar trend towards recovery in the United States. [Extracted from the article]

A recent study examined trends in cervical cancer diagnosis and mortality in the United States, finding that rates of distant-stage cervical cancer and mortality have increased, particularly among Non-Hispanic White women in low-income regions. The study suggests that reduced screening and care for specific subgroups of women, such as those with low income, may be contributing to these findings. In Italy, a national screening program for cervical cancer has been implemented, with 79% of women following a regular screening program. However, attendance rates for the program were lower than 50%, with lower education being a significant factor. The study emphasizes the importance of information and education about the importance of screening and vaccination, as well as the need for national institutions to play a role in these efforts. [Extracted from the article]

An altered balance between metalloproteinases (MMPs) and their inhibitor tissue inhibitor of metalloproteinases (TIMPs) may influence the healing process of a minor amputation following a successful vein graft. To speed up this process, negative pressure wound therapy (NPWT) and advanced moist wound dressing have been proposed. We determined the systemic and local release of MMP‐1, ‐2, ‐3, ‐9, TIMP‐1, and TIMP‐2 by enzyme linked immunosorbent assay (ELISA) technique and their influences in the healing process in 26 patients who underwent minor amputation after a successful revascularisation procedure. Twelve patients (group 1) were medicated with NPWT and 14 (group 2) with advanced moist wound dressing. Plasma samples were collected on the morning of surgery and thereafter at 1, 3, and 5 months; exudates were collected 3 days after surgery when amputation was performed and thereafter at 1, 3, and 5 months. Fifteen age‐matched healthy male volunteers served as controls. All wounds healed in 5 ± 0.5 months. Follow‐up plasma and local release of MMP‐1, ‐2, ‐3, and ‐9 were overall significantly lower when compared with the preoperative levels, while those of TIMP‐1 and ‐2 were significantly higher with no differences among the groups. Despite no differences in the healing process being observed among the two types of medications, at 1 month the local release of MMP‐2 and ‐9 was significantly lower (P =.013 and.047, respectively) and that of TIMP‐1 was significantly higher (P =.042) in group 1 as compared to group 2. A correct and aggressive local approach to the wound is able to promote the healing of the lesion stimulating the extracellular matrix turnover with local MMP/TIMP adequate balance and favouring the creation of granulation tissue. However, a successful restoration of an adequate blood flow remains the key point of a durable and rapid wound healing. [ABSTRACT FROM AUTHOR]

Prodromal signs of a non‐healing wound after revascularisation, which might be strictly linked with impending failure of vascular reconstructions, are associated with an inflammatory response mediated by several circulating adhesion molecules, extracellular endopeptidases, and cytokines. The aim of our study was to investigate the role of selected plasma biomarkers in the prediction of both wound healing and failure of infrapopliteal vein graft or percutaneous trans‐luminal angioplasty (PTA) with selective stent positioning of the superficial femoral artery (SFA) in a population affected with critical limb ischaemia. A total of 68 patients who underwent either surgical or endovascular revascularisation of the inferior limb with autologous saphenous vein infrapopliteal bypass or PTA and selective stenting of the SFA were enrolled in our study. Patients were divided into two groups according to treatment: 41 patients were included in Group 1 (open surgery) and 27 in Group 2 (endovascular procedure). Plasma and blood samples were collected on the morning of surgery and every 6 months thereafter for up to 2 years of follow‐up or until an occlusion occurred of either the vein bypass graft or the vessel treated endovascularly. Fifteen age‐matched healthy male volunteers were considered a reference for biological parameters. Vascular cell adhesion molecule 1 [VCAM‐1]/CD106, inter‐cellular adhesion molecule‐1 [ICAM‐1]/CD54), interleukin‐1 (IL‐1), interleukin‐6 (IL‐6), tumour necrosis factor alpha (TNF‐α), and metalloproteinases (MMP)‐2 and ‐9 plasma levels were measured with enzyme‐linked immunosorbent assay (ELISA) kits. The mean observed time to heal of 54 wounds was 13 ± 4 months, with no statistically significant differences among the groups. The healing failure of the remaining wounds was strictly related to an unsuccessful open (n = 12) or endovascular (n = 8) treatment. The 2‐year primary patency rate was 65% (SE =.09) in Group 1 and 52% (SE =.1) in Group 2. When compared with mean concentration values of Group 1, VCAM‐1 and ICAM‐1 were always significantly higher during follow‐up in patients of Group 2 (P < .05). Furthermore, in the same group, IL‐6 and tumour necrosis factor alpha (TNF‐α) were found to be significantly higher at 6‐ and 12‐month (P < .05) when compared with surgically treated patients. Cox regression analysis showed that elevated plasma levels of VCAM‐1, ICAM‐1, IL‐6, and TNF‐α during follow up were strongly related to impaired wound healing and/or revascularisation failure (P < .05). Elevated plasma levels of inflammatory markers VCAM‐1, ICAM‐1, IL‐6, and TNF‐α may be related to the failure of wound healing and revascularisation procedures. Interestingly, we have observed that endovascular treatments cause a higher level of these inflammation biomarkers when compared with a vein graft, although wound‐healing and patency and limb salvage rates are not influenced. [ABSTRACT FROM AUTHOR]

Abnormal, persistent inflammation after bypass surgery could prevent healing of an ischaemic foot lesion. In 37 patients with peripheral arterial disease (PAD) (Rutherford Grade III Category 5) who underwent infrapopliteal vein graft and midfoot amputation, plasma levels of fibrinogen, C‐reactive protein (CRP), interleukin‐1 (IL‐1), interleukin‐6 (IL‐6), tumour necrosis factor‐α (TNF‐α), and matrix metalloproteinase‐2 and ‐9 (MMP‐2 and MMP‐9) were determined preoperatively and during the follow up. Nine patients without clinical and Doppler evidence of arterial disease, who underwent post‐traumatic midfoot primary amputation, were included in the experiment group, and 15 age‐matched healthy volunteers served as control. In patients who had midfoot amputation for trauma, all wounds healed. Seven (19%) wounds in patients with an occluded graft healed, and five (13%) required major amputation because of a non‐healing wound. Time required for complete healing of the lesion was similar between trauma and PAD patients (8 ± 2 months vs 11 ± 6, respectively, P = NS). Univariate analysis demonstrated that, in PAD patients, the postoperative high levels of TNF‐α, IL‐6, and MMP‐2 and ‐9 were predictive for wound healing failure at 3, 6, and 9 months (P < 0.05), respectively. Furthermore, the subgroup of patients who experienced occlusion of the vein graft during follow up had a significant increase of MMP‐2, ‐9, IL‐6, and TNF‐α at 3, 6, and 9 months (P < 0.05), respectively. Monitoring inflammatory markers allows the determination of patients at risk of healing failure of midfoot amputation after distal revascularisation and might predict the fate of the vein graft. [ABSTRACT FROM AUTHOR]

The aim of our study was to review the changing trends in the treatment of complications from portal hypertension. A short history of portal hypertension and of the treatment of its complications is reported, underlying the most important achievements and changes. [ABSTRACT FROM AUTHOR]

The article focuses on the advantage of using covered stents during malignant gastric outlet obstruction. It talks about advantages including prevention of tumor ingrowth, facilitation of pyloric motility. It discusses how improper diagnosis of food obstruction can result in stomach dilatation, dyspnea and nausea.